Pharmacokinetics of trabectedin on hemodialysis: an application for the management of cancer patients with end-stage renal disease-Reference-Cited by-同舟云学术

Pharmacokinetics of trabectedin on hemodialysis: an application for the management of cancer patients with end-stage renal disease

Published:2011-08-18 Issue:5 Volume:68 Page:1363-1367
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Thariat Juliette,Etienne-Grimaldi Marie-Christine,Launay-Vacher Vincent,Soto-Matos Arturo,Fernandez-Teruel Carlos,Ghafari Thomas,Marcy Pierre-Yves,Milano Gérard,Renée Nicole,Gastaud Lauris,Thyss Antoine

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-011-1718-5.pdf

Reference13 articles.

1. D’Incalci M, Galmarini CM (2010) A review of trabectedin (ET-743): a unique mechanism of action. Mol Cancer Ther 9:2157–2163

2. Beumer JH, Rademaker-Lakhai JM, Rosing H, Hillebrand MJ, Bosch TM, Lopez-Lazaro L, Schellens JH, Beijnen JH (2007) Metabolism of trabectedin (ET-743, Yondelis) in patients with advanced cancer. Cancer Chemother Pharmacol 59:825–837

3. Beumer JH, Schellens JH, Beijnen JH (2005) Hepatotoxicity and metabolism of trabectedin: a literature review. Pharmacol Res 51:391–398

4. Beumer JH, Lopez-Lazaro L, Schellens JH, Beijnen JH, van Tellingen O (2009) Evaluation of human plasma protein binding of trabectedin (Yondelis, ET-743). Curr Clin Pharmacol 4:38–42

5. Sparidans RW, Rosing H, Hillebrand MJ, López-Lázaro L, Jimeno JM, Manzanares I, van Kesteren C, Cvitkovic E, van Oosterom AT, Schellens JH, Beijnen JH (2001) Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in man. Anticancer Drugs 12:653–666

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conventional chemotherapy;Onco-Nephrology;2020

2. Trabectedin: Supportive care strategies and safety profile;Critical Reviews in Oncology/Hematology;2015-06

3. A Comprehensive Safety Evaluation of Trabectedin and Drug–Drug Interactions of Trabectedin-Based Combinations;BioDrugs;2014-09-11

4. Quantification of trabectedin in human plasma: Validation of a high-performance liquid chromatography–mass spectrometry method and its application in a clinical pharmacokinetic study;Journal of Pharmaceutical and Biomedical Analysis;2014-07

5. Safety evaluation of trabectedin in treatment of soft-tissue sarcomas;Expert Opinion on Drug Safety;2013-08-12